Richard B Hubbard
Overview
Explore the profile of Richard B Hubbard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
2524
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chin D, Hernandez-Beeftink T, Donoghue L, Guillen-Uio B, Guillen-Guio B, Leavy O, et al.
medRxiv
. 2025 Feb;
PMID: 39974050
Background: Idiopathic pulmonary fibrosis (IPF) is a rare, incurable lung disease with a median survival of 3-5 years after diagnosis. Treatment options are limited. Genetic association studies can identify new...
2.
Porsbjerg C, Townend J, Bergeron C, Christoff G, Katsoulotos G, Larenas-Linnemann D, et al.
Front Immunol
. 2024 May;
15:1361891.
PMID: 38711495
Background: To date, studies investigating the association between pre-biologic biomarker levels and post-biologic outcomes have been limited to single biomarkers and assessment of biologic efficacy from structured clinical trials. Aim:...
3.
Guillen-Guio B, Paynton M, Allen R, Chin D, Donoghue L, Stockwell A, et al.
ERJ Open Res
. 2024 Feb;
10(1).
PMID: 38375425
Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial pneumonia marked by progressive lung fibrosis and a poor prognosis. Recent studies have highlighted the potential role of infection in the...
4.
Leavy O, Goemans A, Stockwell A, Allen R, Guillen-Guio B, Hernandez-Beeftink T, et al.
medRxiv
. 2024 Jan;
PMID: 38293162
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic lung condition that is more prevalent in males than females. The reasons for this are not fully understood, with differing environmental exposures...
5.
Guillen-Guio B, Paynton M, Allen R, Chin D, Donoghue L, Stockwell A, et al.
medRxiv
. 2023 Aug;
PMID: 37546732
Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial pneumonia marked by progressive lung fibrosis and a poor prognosis. Recent studies have highlighted the potential role of infection in the...
6.
Allen R, Oldham J, Jenkins D, Leavy O, Guillen-Guio B, Melbourne C, et al.
Lancet Respir Med
. 2022 Aug;
11(1):65-73.
PMID: 35985358
Background: Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease characterised by progressive scarring leading to alveolar stiffness, reduced lung capacity, and impeded gas transfer. We aimed to identify genetic...
7.
Nartey Y, Tata L, Khakwani A, Beattie V, Beckett P, Hubbard R, et al.
Support Care Cancer
. 2022 Feb;
30(5):4417-4428.
PMID: 35106657
Purpose: Identification of unmet needs in person centred and supportive care could be limited by differences in experience across specific cancer populations. Using the experiences of people with lung cancer,...
8.
ODowd E, Ten Haaf K, Kaur J, Duffy S, Hamilton W, Hubbard R, et al.
Thorax
. 2021 Oct;
77(9):882-890.
PMID: 34716280
Method: The Clinical Practice Research Datalink, a computerised, longitudinal primary care database, was used to evaluate the Liverpool Lung Project V.2 (LLP) and Prostate Lung Colorectal and Ovarian (modified 2012)...
9.
Jones G, Khakwani A, Pascoe A, Foweraker K, McKeever T, Hubbard R, et al.
Ann Palliat Med
. 2021 Apr;
10(4):4055-4068.
PMID: 33894719
Background: The mainstay of treatment for small cell lung cancer (SCLC) involves platinum doublet chemotherapy but the optimal duration, 4 vs. 6 cycles, is not known. Concurrent thoracic radiotherapy followed...
10.
Johnston P, Wright S, Orr M, Pearce F, Stevens J, Hubbard R, et al.
AIDS
. 2021 Jan;
35(6):957-970.
PMID: 33470609
Objective And Design: People living with HIV (PLH) suffer disproportionately from the chronic diseases exacerbated by smoking tobacco. We performed a systematic review and meta-analysis to establish the relative prevalence...